1 |
Meyer PA, Seward JF, Jumaan AO, Wharton M. Varicella mortality : trends before vaccine licensure in the United States, 1970-1994. J Infect Dis 2000;182:383-90
DOI
|
2 |
Sheffer R, Segal D, Rahamani S, Datal H, Linhart Y, Stein M, et al. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel. Pediatr Infect Dis J 2005;24:434-7
DOI
ScienceOn
|
3 |
Galil K, Fair E, Mountcastle N, Britz P, Seward J, Younger age at vaccination may increase risk of varicella vaccine failure. J infect Dis 2002;186:102-5
DOI
ScienceOn
|
4 |
Lee BR, Feaver SL, Miller CA, Hedberg CW, Ehresmann KR. An elementary school outbreak of varicella attributed to vaccine failure : policy implications. J Infect Dis 2004;190: 477-83
|
5 |
Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicellavaccination in the United States. N Engl J Med 2005;352:450-8.
DOI
ScienceOn
|
6 |
Volpi A. Varicella immunization and herpes zoster. Herpes 2005;12:59
|
7 |
Brisson M, Edmunds WJ. Varicella vaccination in England and Wales : cost-utility analysis. Arch Dis Child 2003;88: 862-9
DOI
|
8 |
Reisinger KS, Brown ML, Xu J, Sullivan BJ, Marshall GS, Nauert B, et al. A combination measles, mumps, rubella, and varicella vaccine(ProQuad) given to 4-to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax. Pediatrics 2006;117:265-72
DOI
ScienceOn
|
9 |
Watson B, Seward J, Yang A, Witte P, Lutz J, Chan C, et al. Postexposure effectiveness of varicella vaccine. Pediatrics 2000;105:85-8
DOI
ScienceOn
|
10 |
Kang JH, Kim JH, Suh BK. The Immunogenicity and safety study of 47 passaged Oka strain live attenuated varicella vaccine in healthy children. Korean J Pediatr Infect Dis 1997;4:257-64
DOI
|
11 |
Takahashi M. Effectiveness of live varicella vaccine. Expert Opin Biol Ther 2004;4:199-216
DOI
ScienceOn
|
12 |
Weibel RE, Kuter BJ, Neff BJ, Rothenberger CA, Fitzgerald AJ, Connor KA, et al. Live Oka/Merck varicella vaccine in healthy children. Further clinical and laboratory assessment. JAMA 1985;254:2435-9
DOI
|
13 |
Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA 2005;294:797-802
DOI
ScienceOn
|
14 |
White CJ, Kuter BJ, Hilderbrand CS, Isganitis KL, Matthews H, Miller WJ, et al. Varicella vaccine(Varivax) in healthy children and adolescents : results from clinical trials, 1987-89. Pediatrics 1991;87:604-10
|
15 |
Li, Shu, Chan ISF, Matthews H, Heyse J, Chan CY. Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection. Pediatr Infect Dis J 2002;21:337-42
DOI
ScienceOn
|
16 |
Kim MR, Park JS, Kim DH, Lee HR, Park CY. A clinical and epidemiologic study on varicella in children. Korean J Pediatr Inf Dis 1998;5:88-95
|
17 |
Shinefield H, Black S, Digilio L, Reisinger K, Blatter M, Gress JO, et al. Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine inhealthy children. Pediatr Infect Dis J 2005;24:665-9
DOI
ScienceOn
|
18 |
Hall S, Maupin T, Seward J, Jumaan AO, Peterson C, Goldman G, et al. Second varicella infections : Are they more common than previously thought- Pediatrics 2002;19:1068-73
|
19 |
Seward J, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002;287:606-11
DOI
|
20 |
Brisson and Edmuds. The cost-effectiveness of varicella vaccination in Canada. Vaccine 2002;20:1113-25
DOI
ScienceOn
|
21 |
Morales-Castillo ME, Alvarez-Muñoz MT, Solórzano-Santos F, González-Robledo R, Jasso-Gutiérrez L, Muñoz-Hernández O. Live varicella vaccine in both immunocompromised and healthy children. Arch Medl Res 2002;31:85-7
|
22 |
Vazquez M, LaRussa PS, Gershon AA, Niccolai LM, Nuehlenbein CE, Steinberg SP, et al. Effectiveness over time of varicella vaccine. JAMA 2004;291:851-5
DOI
ScienceOn
|
23 |
Kim DJ, Park HS, Lee SY, Park KS, Kim TK, Song YH, et al. Epidemiology of varicella in Korea based on pediatrician's office practice. J Korean Pediatr Soc 1997;40:73-81
|
24 |
Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults : a case-control study. Lancet 2002;360:678-82
DOI
ScienceOn
|
25 |
Katsushima N, Yazaki N, Sakamoto M. Effect and followup study on varicella vaccine. Biken J 1984;27:51-8
|
26 |
Johnson CE, Stancin T, Fattlar D, Rome LP, Kumar ML. A long-term prospective study of varicella vaccine in healthy children. Pediatrics 1997;100:761-6
DOI
ScienceOn
|
27 |
LaRussa P, Steinberg S, Gershon AA. Varicella vaccine for immunocompromised children : results of collaborativestudies in the United States and Canada. J Infect Dis 1996;174: S320-3
DOI
|
28 |
Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, et al. Invasive Group A streptococcal infections in Ontario, Canada. N Engl J Med 1996;335:547-54
DOI
ScienceOn
|
29 |
Goldman GS. Incidence of herpes zoster among children and adolescents in a community with moderate varicella vaccination coverage. Vaccine 2003;21:4243-9
DOI
ScienceOn
|
30 |
Varis T, Vesikari T. Efficacy of high-titer live attenuated varicella vaccine in healthy young children. J Infect Dis 1996;174 Suppl 3:S330-4
DOI
|
31 |
Health Canada. Proceedings of the national varicella consensus conference. CCDR 1999;25:1-29
|
32 |
Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster : implications for mass vaccination against chickenpox. Vaccine 2002;20:2500-7
DOI
ScienceOn
|
33 |
Grose C. Varicella vaccination of children in the United States : Assessment after the first decade 1995-2005. J Clin Virol 2005;33:89-95
DOI
ScienceOn
|
34 |
Galil K, Lee B, Strine T, Carraher C, Baughman AL, Eaton M, et al. Outbreak of varicella at a day-care center despite vaccination. N Engl J Med 2002;347:1909-15
DOI
ScienceOn
|
35 |
Arvin AM, Gershon AA. Live attenuated varicella vaccine. 1996 Annu Rev Microbiol 1996;50:59-100
DOI
ScienceOn
|